Curcumin inhibits glucose production in isolated mice hepatocytes

Diabetes Research and Clinical Practice

Volumn 80, Issue 2, 2008, Pages 185-191

  Fujiwara, Hideya ^a   Hosokawa, Masaya ^a   Zhou, Xiaorong ^a   Fujimoto, Shimpei ^a   Fukuda, Kazuhito ^a   Toyoda, Kentaro ^a   Nishi, Yuichi ^a   Fujita, Yoshihito ^a   Yamada, Kotaro ^a   Yamada, Yuichiro ^a   Seino, Yutaka ^a,b   Inagaki, Nobuya ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KANSAI DENRYOKU HOSPITAL   (Japan)

Author keywords

Curcumin; Diabetes mellitus; Liver; Mice

Indexed keywords

ADENYLATE KINASE; ANTIDIABETIC AGENT; ANTIOXIDANT; CURCUMIN; DIHYDROXYACETONE PHOSPHATE; FRUCTOSE BISPHOSPHATASE; GLUCOSE 6 PHOSPHATASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME INHIBITION; EXPOSURE; GLUCONEOGENESIS; GLYCOGENOLYSIS; IMMUNOBLOTTING; INHIBITION KINETICS; LIVER CELL; MOUSE; NONHUMAN;

ANIMALS; CURCUMIN; DNA REPLICATION; FRUCTOSE-BISPHOSPHATASE; GLUCONEOGENESIS; GLUCOSE; HEPATOCYTES; MICE; MICE, INBRED C57BL; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP);

EID: 41749104639     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.12.004     Document Type: Article

References (22)

1. Srimal R.C., and Dhawan B.N. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J. Pharm. Pharmacol. 25 (1973) 447-452
2. Joe B., and Lokesh B.R. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim. Biophys. Acta 1224 (1994) 255-263
3. Reddy A.C., and Lokesh B.R. Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron. Mol. Cell. Biochem. 137 (1994) 1-8
4. Kiso Y., Suzuki Y., Watanabe N., Oshima Y., and Hikino H. Antihepatotoxic principles of Curcuma longa rhizomes. Planta Med. 49 (1983) 185-187
5. Rao D.S., Sekhara N.C., Satyanarayana M.N., and Srinivasan M. Effect of curcumin on serum and liver cholesterol levels in the rat. J. Nutr. 100 (1970) 1307-1315
6. Patil T.N., and Srinivasan M. Hypocholesteremic effect of curcumin in induced hypercholesteremic rats. Indian J. Exp. Biol. 9 (1971) 167-169
7. Arun N., and Nalini N. Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum. Nutr. 57 (2002) 41-52
8. Nishiyama T., Mae T., Kishida H., Tsukagawa M., Mimaki Y., Kuroda M., et al. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. J. Agric. Food Chem. 53 (2005) 959-963
9. Hosokawa M., and Thorens B. Glucose release from GLUT2-null hepatocytes: characterization of a major and a minor pathway. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E794-E801
10. Uldry M., Ibberson M., Hosokawa M., and Thorens B. GLUT2 is a high affinity glucosamine transporter. FEBS Lett. 524 (2002) 199-203
11. Aoki K., Saito T., Satoh S., Mukasa K., Kaneshiro M., Kawasaki S., et al. Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone. Diabetes 48 (1999) 1579-1585
12. Passoneau J.V., and Lowry O.H. Enzymic Analysis: A Practical Guide by Passoneau JV and Lowry OH. (1993), Humana Press, Totowa, NJ pp. 249-253
13. Nakagawa H., and Nagai K. Cold adaptation. I. Effect of cold-exposure on gluconeogenesis. J. Biochem. (Tokyo) 69 (1971) 923-934
14. Shen S.Q., Zhang Y., Xiang J.J., and Xiong C.L. Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes. World J. Gastroenterol. 13 (2007) 1953-1961
15. Mithieux G., Guignot L., Bordet J.C., and Wiernsperger N. Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet. Diabetes 51 (2002) 139-143
16. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108 (2001) 1167-1174
17. Lochhead P.A., Salt I.P., Walker K.S., Hardie D.G., and Sutherland C. 5-Aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes 49 (2000) 896-903
18. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8 (2002) 1288-1295
19. Zang M., Xu S., Maitland-Toolan K.A., Zuccollo A., Hou X., Jiang B., et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55 (2006) 2180-2191
20. Kim E.J., Jung S.N., Son K.H., Kim S.R., Ha T.Y., Park M.G., et al. Antidiabetes and antiobesity effect of cryptotanshinone via activation of AMP-activated protein kinase. Mol. Pharmacol. 72 (2007) 62-72
21. Sharma R.A., Euden S.A., Platton S.L., Cooke D.N., Shafayat A., Hewitt H.R., et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin. Cancer Res. 10 (2004) 6847-6854
22. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21 (2001) 2895-2900